MGX ▲ +1.3% - Metagenomi Therapeutics, Inc. $MGX - Metagenomi Therapeutics to Present Preclinical Data Supporting MGX-001, a Potential One-Time Therapy for Hemophilia A, in Oral Presentation at 68th American Society of Hematology Annual Meeting 04-NOV-2026 09:25 AM ET